Literature DB >> 35042955

"Blasts" in myeloid neoplasms - how do we define blasts and how do we incorporate them into diagnostic schema moving forward?

Xueyan Chen1, Jonathan R Fromm1, Kikkeri N Naresh2,3.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35042955     DOI： 10.1038/s41375-021-01498-6

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  45 in total

1.  Bone marrow aspirate collection and preparation--a comparison of three methods.

Authors:  Teresa DiFrancesco; Duane J Boychuk; John D Lafferty; Mark A Crowther
Journal:  Clin Invest Med       Date:  2012-06-01       Impact factor: 0.825

2.  ICSH guidelines for the standardization of bone marrow specimens and reports.

Authors:  S-H Lee; W N Erber; A Porwit; M Tomonaga; L C Peterson
Journal:  Int J Lab Hematol       Date:  2008-10       Impact factor: 2.877

Review 3.  Digital morphology analyzers in hematology: ICSH review and recommendations.

Authors:  Alexander Kratz; Szu-Hee Lee; Gina Zini; Jurgen A Riedl; Mina Hur; Sam Machin
Journal:  Int J Lab Hematol       Date:  2019-05-02       Impact factor: 2.877

4.  Flow cytometric monitoring of residual disease in acute leukemia.

Authors:  Brent L Wood
Journal:  Methods Mol Biol       Date:  2013

Review 5.  Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis.

Authors:  Xueyan Chen; Sindhu Cherian
Journal:  Clin Lab Med       Date:  2017-08-31       Impact factor: 1.935

6.  Limitations of poor bone marrow aspirations (for an accurate diagnosis) despite the multimodal analytical era: A longitudinal retrospective study.

Authors:  John M Astle; Mina L Xu; Tamir Friedman; Elliott Brown
Journal:  Am J Hematol       Date:  2017-08-24       Impact factor: 10.047

7.  Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.

Authors:  Prisca Theunissen; Ester Mejstrikova; Lukasz Sedek; Alita J van der Sluijs-Gelling; Giuseppe Gaipa; Marius Bartels; Elaine Sobral da Costa; Michaela Kotrová; Michaela Novakova; Edwin Sonneveld; Chiara Buracchi; Paola Bonaccorso; Elen Oliveira; Jeroen G Te Marvelde; Tomasz Szczepanski; Ludovic Lhermitte; Ondrej Hrusak; Quentin Lecrevisse; Georgiana Emilia Grigore; Eva Froňková; Jan Trka; Monika Brüggemann; Alberto Orfao; Jacques J M van Dongen; Vincent H J van der Velden
Journal:  Blood       Date:  2016-11-30       Impact factor: 22.113

8.  A dissection of the CD45/side scatter "blast gate".

Authors:  Alexandra M Harrington; Horatiu Olteanu; Steven H Kroft
Journal:  Am J Clin Pathol       Date:  2012-05       Impact factor: 2.493

Review 9.  Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.

Authors:  Gerrit J Schuurhuis; Michael Heuser; Sylvie Freeman; Marie-Christine Béné; Francesco Buccisano; Jacqueline Cloos; David Grimwade; Torsten Haferlach; Robert K Hills; Christopher S Hourigan; Jeffrey L Jorgensen; Wolfgang Kern; Francis Lacombe; Luca Maurillo; Claude Preudhomme; Bert A van der Reijden; Christian Thiede; Adriano Venditti; Paresh Vyas; Brent L Wood; Roland B Walter; Konstanze Döhner; Gail J Roboz; Gert J Ossenkoppele
Journal:  Blood       Date:  2018-01-12       Impact factor: 25.476

10.  Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter setting.

Authors:  N Feller; V H J van der Velden; R A Brooimans; N Boeckx; F Preijers; A Kelder; I de Greef; G Westra; J G Te Marvelde; P Aerts; H Wind; M Leenders; J W Gratama; G J Schuurhuis
Journal:  Blood Cancer J       Date:  2013-08-02       Impact factor: 11.037
View more
  1 in total

Review 1.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Authors:  Joseph D Khoury; Eric Solary; Oussama Abla; Yassmine Akkari; Rita Alaggio; Jane F Apperley; Rafael Bejar; Emilio Berti; Lambert Busque; John K C Chan; Weina Chen; Xueyan Chen; Wee-Joo Chng; John K Choi; Isabel Colmenero; Sarah E Coupland; Nicholas C P Cross; Daphne De Jong; M Tarek Elghetany; Emiko Takahashi; Jean-Francois Emile; Judith Ferry; Linda Fogelstrand; Michaela Fontenay; Ulrich Germing; Sumeet Gujral; Torsten Haferlach; Claire Harrison; Jennelle C Hodge; Shimin Hu; Joop H Jansen; Rashmi Kanagal-Shamanna; Hagop M Kantarjian; Christian P Kratz; Xiao-Qiu Li; Megan S Lim; Keith Loeb; Sanam Loghavi; Andrea Marcogliese; Soheil Meshinchi; Phillip Michaels; Kikkeri N Naresh; Yasodha Natkunam; Reza Nejati; German Ott; Eric Padron; Keyur P Patel; Nikhil Patkar; Jennifer Picarsic; Uwe Platzbecker; Irene Roberts; Anna Schuh; William Sewell; Reiner Siebert; Prashant Tembhare; Jeffrey Tyner; Srdan Verstovsek; Wei Wang; Brent Wood; Wenbin Xiao; Cecilia Yeung; Andreas Hochhaus
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.